SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001140361-22-015844
Filing Date
2022-04-26
Accepted
2022-04-26 07:16:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9 ny20003961x1_sc14d9.htm SC 14D9 745171
  Complete submission text file 0001140361-22-015844.txt   747353
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filed by) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Subject) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-47575 | Film No.: 22851745
SIC: 3841 Surgical & Medical Instruments & Apparatus